In addition, logistic regression analysis revealed that C-Peptide, not insulin, is an independent risk factor of NAFLD, which may indicate that NAFLD has a stronger association with C-Peptide than insulin. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.